Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 16 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
15(93.8%)
Phase 2
1(6.3%)
16Total
Phase 1(15)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT01834079Phase 1Unknown

Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease

Role: lead

NCT01914913Phase 1Unknown

Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa

Role: lead

NCT01834664Phase 1Unknown

Safety and Efficacy of Bone Marrow Derived Autologous Cells Treatment of Cerebral Palsy in Subjects Above 15 Years

Role: lead

NCT01836562Phase 1Unknown

A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism

Role: lead

NCT01834066Phase 1Unknown

Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.

Role: lead

NCT01834040Phase 1Unknown

Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy

Role: lead

NCT01958177Phase 1Unknown

Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia

Role: lead

NCT01832441Phase 1Unknown

Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus.

Role: lead

NCT01876017Phase 1Unknown

Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure

Role: lead

NCT01834053Phase 1Unknown

Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.

Role: lead

NCT01883661Phase 1Unknown

Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)

Role: lead

NCT01832428Phase 1Unknown

A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke.

Role: lead

NCT01833975Phase 1Unknown

Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury

Role: lead

NCT01908400Phase 1Unknown

Safety and Efficacy of BMMNCin Patients With Mental Retardation

Role: lead

NCT01832454Phase 2Unknown

Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years

Role: lead

NCT01877759Phase 1Unknown

A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis

Role: lead

All 16 trials loaded